Danaher Corporation $DHR Stock Holdings Lessened by SG Americas Securities LLC

SG Americas Securities LLC lessened its holdings in shares of Danaher Corporation (NYSE:DHR) by 57.9% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 56,887 shares of the conglomerate’s stock after selling 78,290 shares during the period. SG Americas Securities LLC’s holdings in Danaher were worth $11,278,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of DHR. WFA of San Diego LLC acquired a new position in Danaher in the second quarter valued at approximately $26,000. Howard Hughes Medical Institute acquired a new stake in shares of Danaher during the 2nd quarter worth approximately $27,000. TruNorth Capital Management LLC bought a new stake in shares of Danaher in the 3rd quarter worth approximately $28,000. Tripletail Wealth Management LLC bought a new stake in shares of Danaher in the 3rd quarter worth approximately $31,000. Finally, Red Tortoise LLC boosted its position in Danaher by 175.0% during the 2nd quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock valued at $30,000 after purchasing an additional 98 shares during the period. Institutional investors and hedge funds own 79.05% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have weighed in on DHR. Jefferies Financial Group increased their target price on Danaher from $245.00 to $255.00 and gave the stock a “buy” rating in a research report on Wednesday, December 17th. HSBC upped their price target on shares of Danaher from $255.00 to $270.00 and gave the stock a “buy” rating in a research report on Monday, December 1st. Redburn Partners set a $220.00 price objective on shares of Danaher in a research report on Wednesday, October 8th. Weiss Ratings reissued a “hold (c)” rating on shares of Danaher in a research note on Monday, December 29th. Finally, Morgan Stanley started coverage on shares of Danaher in a research note on Monday, December 1st. They issued an “overweight” rating and a $270.00 price target on the stock. Twenty-one investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Danaher has an average rating of “Moderate Buy” and an average target price of $249.92.

Danaher Stock Performance

Shares of DHR opened at $238.28 on Friday. The firm has a market capitalization of $168.31 billion, a PE ratio of 49.13, a P/E/G ratio of 4.18 and a beta of 0.89. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.33. The firm has a 50-day moving average price of $225.77 and a 200 day moving average price of $210.51. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $258.23.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Monday, October 20th. The conglomerate reported $1.89 earnings per share for the quarter, topping analysts’ consensus estimates of $1.72 by $0.17. The company had revenue of $6.05 billion during the quarter, compared to analyst estimates of $6 billion. Danaher had a net margin of 14.44% and a return on equity of 10.92%. The business’s revenue for the quarter was up 4.4% compared to the same quarter last year. During the same period in the prior year, the business posted $1.71 EPS. On average, sell-side analysts anticipate that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Friday, December 26th will be paid a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a yield of 0.5%. The ex-dividend date of this dividend is Friday, December 26th. Danaher’s dividend payout ratio (DPR) is presently 26.39%.

Insider Activity

In other news, SVP Brian W. Ellis sold 21,776 shares of the business’s stock in a transaction on Wednesday, November 12th. The stock was sold at an average price of $219.23, for a total value of $4,773,952.48. Following the sale, the senior vice president owned 14,553 shares of the company’s stock, valued at approximately $3,190,454.19. The trade was a 59.94% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Teri List sold 3,298 shares of the company’s stock in a transaction on Tuesday, November 18th. The shares were sold at an average price of $226.50, for a total value of $746,997.00. Following the completion of the sale, the director owned 20,762 shares of the company’s stock, valued at approximately $4,702,593. This trade represents a 13.71% decrease in their position. The SEC filing for this sale provides additional information. In the last ninety days, insiders have sold 30,248 shares of company stock worth $6,609,663. 11.10% of the stock is owned by company insiders.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.